MoneyWorks4Me

Dr. Reddy’s Laboratories informs about updates

28 Oct 2023 Evaluate

Dr. Reddy’s Laboratories has informed that the United States Food & Drug Administration (USFDA) completed a routine cGMP inspection at its formulations manufacturing facility (FTO-3) in Bachupally, Hyderabad. The inspection was conducted from October 19, 2023 to October 27, 2023. The company has been issued a Form 483 with ten observations, which will address within the stipulated timeline.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1834.85
Dr. Reddys Labs. 1159.85
Cipla 1355.30
Lupin 2074.65
Zydus Lifesciences 1110.90
View more..